11:41 AM EST - Cipher Pharmaceuticals Inc : announced its financial and operational results for the 12 months ended December 31, 2013. Total revenue was $27.0 million, compared with $8.5 million in 2012. EBITDA was $20.0 million versus $3.8 million in 2012. Net income in 2013 was $25.0 million, or $1.02 per basic share, compared with net income of $2.5 million, or $0.10 per basic share, in 2012. Cipher Pharmaceuticals Inc
shares T.DND are trading up $0.23 at $8.45.
